Exercise Physiology at Altitude
Key Terminology
- Hypobaria – low atmospheric (barometric) pressure.
- Hypoxia – low oxygen availability in tissues or environment.
- Hypoxemia – low PO<em>2 (partial pressure of O$2$) in arterial blood.
- Altitude (for this lecture) – any elevation > 1{,}500\text{ m} above sea level.
- Barometric pressure (P\text{bar}) vs. PO2
- Pbar falls with elevation; %O$_2$ in the air (~21 %) remains constant.
- Lower Pbar ⇒ lower PO<em>2 ⇒ less O$2$ available to load onto Hb.
Atmospheric & Environmental Conditions at Altitude
- Sea-level Pbar≈760 mmHg; Mt. Everest summit ≈260 mmHg (varies with weather, season & locale).
- Temperature lapse rate: air temp ↓ ≈ 10∘C(1.8∘F) every 150 m gained.
- High winds common ⇒ ↑ convective & evaporative heat loss; ↑ risk of cold injuries.
- Low absolute water-vapor pressure; cold air holds minimal moisture:
- Skin: steep H$_2$O gradient ⇒ rapid evaporation ⇒ dehydration.
- Lungs: ↑ respiratory water loss (further amplified by altitude-induced hyperventilation).
- Solar radiation ↑ markedly:
- Thinner air + ↓ water vapor ⇒ less absorption ≈ more UV/short-wave radiation reaching surface.
- Snow/ice reflectivity amplifies exposure ("albedo effect").
Acute Physiological Responses (Minutes → Days)
Pulmonary Ventilation
- Immediate chemoreceptor drive (carotid & aortic bodies) to low PO2 ⇒ ventilation ↑ within seconds.
- ↑ tidal volume + ↑ respiratory rate.
- Respiratory alkalosis develops (↓ PaCO<em>2) ⇒ kidneys excrete HCO$3^- to restore pH; this renal compensation stabilises ventilation after several days.
- Hb–O$2$ dissociation curve shifts left (↑ Hb affinity) because of alkalosis; partially counterbalances low ambient PO2.
Pulmonary Diffusion
- At altitude the alveolar–arterial O$2$ gradient is already depressed; diffusion capacity itself is unchanged, so arterial hypoxemia directly mirrors low alveolar PO2.
O$_2$ Transport (Blood)
- Fewer Hb binding sites reach saturation:
- Sea level: \text{Sa}O_2 \approx 96–97\%.
- Moderate altitude: \text{Sa}O_2 \approx 80–89\% (depends on height).
- Diffusion gradient muscle ↔︎ blood shrinks:
- Sea level: P\text{a}O2 \approx 100\text{ mmHg}totissueP\text{O}2 \approx 40\text{ mmHg}(∆≈60\text{ mmHg}).
- High altitude: P\text{a}O2 \approx 42\text{ mmHg}totissue\approx 27\text{ mmHg}(∆≈15\text{ mmHg}) ⇒ impaired O$2$ unloading and aerobic performance.
Cardiovascular Adjustments
- Plasma volume ↓ up to 25 % (days–weeks): respiratory H$_2$O loss + altitude diuresis.
- Acute hemoconcentration ↑ hematocrit ⇒ more O$_2$ per unit blood but ↑ viscosity.
- Kidneys release erythropoietin (EPO) ⇒ RBC production ↑ (slower, unfolding over weeks).
- Cardiac output (CO)
- Rest & sub-max exercise: CO ↑ via sympathetic surge (↑ HR, modest ↓ SV) for first 6–10 days.
- Max exercise: ↓ SV (from ↓ plasma volume) + slightly ↓ maximal HR ⇒ max CO ↓.
- Basal metabolic rate (BMR) ↑ from ↑ thyroxine and catecholamines ⇒ ↑ caloric need; appetite usually ↓.
- Reliance on carbohydrate ↑ (CHO yields more ATP per O$_2$).
- At first: blood lactate during sub-max ↑ (greater anaerobic glycolysis). After extended stay: lactate response ↓ (“lactate paradox”).
- Nutrition priorities: ample water (>3 L · day$^{-1}$), energy balance, and dietary iron (support erythropoiesis).
- \dot{V}O2\,\text{max}fallsonceambientPO2 < 131\text{ mmHg}( 1500m).Dropisroughlylinearfrom1500–5000mduetoarterialPO_2 reduction; above 5 000 m, lower max CO adds further limitation.
- Anaerobic or brief, glycolytic tasks largely preserved or may improve slightly (↓ air density ⇒ ↓ aerodynamic drag) at moderate altitude.
Chronic Exposure & Acclimatization (Weeks → Months)
Ventilatory Adaptation
- Resting ventilation plateaus ≈ 40 % above sea level after 3–4 days at 4 000 m.
- Sub-max exercise ventilation climbs ≈ 50 % above baseline and remains elevated long-term.
Hematological Adaptations
- First 2 weeks: EPO peaks ⇒ RBC count & Hb mass rise.
- By 6 weeks: total blood volume ↑ ≈ 10 % (plasma partially restored; RBC mass stays high).
- Sea-level hematocrit 45–48 %; Peruvian Andean residents 60–65 %; 6 weeks of exposure in Peru produced ≈ 59 % Hct in study subjects.
- ↑ Hb content ⇒ ↑ O$_2$-carrying capacity, but sea-level values are not fully restored.
Muscle Adaptations
- After 4–6 weeks of >2 500 m exposure (mountain-climber data):
- Muscle fiber CSA ↓ (atrophy from negative energy balance + hypoxia).
- Capillary density ↑ (angiogenesis) ⇒ improved O$_2$ diffusion distance.
- Mitochondrial function & glycolytic enzyme activity ↓ ⇒ reduced oxidative & glycolytic potential; impaired ATP resynthesis capacity.
- Athletes training chronically at altitude struggle to hit sea-level intensity targets because their absolute \dot{V}O_2\,\text{max}$$ remains depressed.
Genetic / Epigenetic High-Altitude Adaptations
- Tibetans (high-altitude natives):
- Larger chest circumference; ↑ total lung capacity (TLC), vital capacity (VC), residual volume (RV), tidal volume (TV).
- Blunted hypoxic pulmonary vasoconstriction → lower pulmonary arterial pressures.
- Normal Hb concentration (vs. Andean polycythemia) yet higher O$_2$ saturation via more efficient ventilatory pattern.
- Stronger myocardium & enhanced cardiac efficiency.
- Skeletal muscle: ↑ capillary density, smaller fibers, preference for glucose oxidation, low lactate accumulation.
Practical / Ethical Implications
- Hydration & iron supplementation are critical to mitigate dehydration & support EPO-mediated erythropoiesis.
- Cold injury & UV exposure risk require protective clothing & eye-wear.
- Athletes may exploit “Live High – Train Low” strategy: reside at ~2 000–2 500 m to gain hematological benefits yet train near sea level to preserve high-intensity capability.
- Doping concern: exogenous EPO or blood transfusion mimics altitude-induced polycythemia.